Fusion Antibodies Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Cap	13	6	2	10	16	40
Market Cap Growth	31.39%	183.03%	-79.20%	-35.66%	-61.05%	90.46%
Enterprise Value	13.58	5.56	0.93	9.9	13.59	37.51
Last Close Price	0.10	0.06	0.04	0.39	0.60	1.57
PS Ratio	8.42	3.00	1.83	3.45	3.24	9.60
PB Ratio	18.51	8.81	1.16	8.92	4.23	8.42
P/TBV Ratio	14.76	8.81	1.16	8.92	4.23	8.42
EV/Sales Ratio	8.51	2.83	0.82	3.41	2.83	9.01
Debt / Equity Ratio	0.39	0	0.01	0.04	0.00	0.01
Net Debt / Equity Ratio	0.19	-0.51	-0.64	-0.11	-0.54	-0.52
Net Debt / EBITDA Ratio	-0.10	0.20	0.56	0.05	3.45	4.59
Net Debt / FCF Ratio	-0.11	0.25	0.65	0.06	3.37	1.64
Asset Turnover	1.02	1.05	0.51	0.83	0.89	0.70
Inventory Turnover	4.60	4.21	2.36	4.14	4.38	5.22
Quick Ratio	1.45	1.59	3.09	1.31	3.06	4.24
Current Ratio	1.80	2.02	3.87	1.92	3.54	4.72
Return on Equity (ROE)	-210.32%	-139.16%	-152.68%	-108.01%	-28.47%	-60.65%
Return on Assets (ROA)	-93.10%	-91.63%	-99.29%	-74.39%	-22.20%	-48.27%
Return on Invested Capital (ROIC)	-169.30%	-354.69%	-271.34%	-191.73%	-59.71%	-96.35%
Return on Capital Employed (ROCE)	-175.29%	-140.30%	-151.57%	-116.89%	-31.03%	-25.27%
Buyback Yield / Dilution	-31.30%	-72.58%	-113.55%	-0.27%	-1.91%	-15.24%
Total Shareholder Return	-31.30%	-72.58%	-113.55%	-0.27%	-1.91%	-15.24%